Skip to main content
PBYI logo
PBYI
(NASDAQ)
Puma Biotechnology, Inc.
$7.67-- (--)
Loading... - Market loading

Puma Biotechnology (PBYI) Stock Price & Financial Analysis

Puma Biotechnology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.26 - $7.59
52-Week High$7.90
52-Week Low$3.03
Open$7.36
Volume427.44K
Average Volume (3M)245.28K
Market Cap384.39M
Shares Outstanding50.85M
P/E Ratio (TTM)15.76
Forward P/E24.62
Price to Sales (P/S)1.69
Price to Book (P/B)2.99
EV/EBITDA8.11
Revenue (TTM)227.18M
Net Income (TTM)24.38M
Free Cash Flow (TTM)53.60M
EPS (TTM)$0.48
Profit Margin10.73%
Operating Margin12.98%
Return on Equity (ROE)18.99%
Debt to Equity0.12
50-Day MA$7.26
200-Day MA$6.13
52-Week Change122.35%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Puma Biotechnology

What is the current stock price for PBYI?

As of the latest trading session, PBYI stock trades at $7.56. The 52-week range is $3.03–$7.90, with a day range of $7.26–$7.59.

What is the P/E ratio for PBYI?

Puma Biotechnology's trailing P/E ratio is 15.8, meaning investors pay $15.8 for every $1 of annual earnings. The forward P/E is 24.6, reflecting analyst expectations for future earnings. Puma Biotechnology operates in the Healthcare sector.

Does PBYI pay dividends?

Puma Biotechnology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PBYI?

Analyst ratings and recommendations for PBYI are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of PBYI?

Puma Biotechnology's market capitalization is $384.4M, classifying it as a small-cap company. Puma Biotechnology operates in the Healthcare sector within the Biotechnology industry.